FDA Senior Official George F. Tidmarsh Placed on Leave Amid Disputes Over Drug Approval Program

Dr. George F. Tidmarsh, a senior official at the Food and Drug Administration (FDA), has been placed on administrative leave amid internal disputes regarding a new program designed to expedite the approval of medications. Dr. Tidmarsh, who serves as a top regulator within the agency, stated that disagreements surrounding the implementation of this program have contributed to what he described as a “toxic” work environment.

The program in question aims to streamline the drug approval process, allowing certain medications to reach patients more quickly. According to Dr. Tidmarsh, tensions arose between him and other agency officials over differing perspectives on how the initiative should be executed. While specific details about these disagreements remain unclear, his removal from active duties highlights ongoing challenges within the FDA as it seeks to balance innovation in drug approvals with regulatory oversight. The agency has not yet provided further comment on Dr. Tidmarsh’s claims or his current employment status.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 2, 2025

Author

GOAI